ID: ALA30553

Max Phase: Preclinical

Molecular Formula: C11H15ClFN5O4S

Molecular Weight: 367.79

Molecule Type: Small molecule

Representations

Canonical SMILES:  CSC(CCNC(=O)N(CCCl)N=O)n1cc(F)c(=O)[nH]c1=O

Standard InChI:  InChI=1S/C11H15ClFN5O4S/c1-23-8(17-6-7(13)9(19)15-11(17)21)2-4-14-10(20)18(16-22)5-3-12/h6,8H,2-5H2,1H3,(H,14,20)(H,15,19,21)

Standard InChI Key:  FZWOVKLNSYNLSA-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 367.79

Molecular Weight (Monoisotopic): 367.0517

AlogP: 0.86

#Rotatable Bonds: 8

Polar Surface Area: 116.63

Molecular Species: NEUTRAL

HBA: 7

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 9

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 8.11

CX Basic pKa:

CX LogP: 1.01

CX LogD: 0.94

Aromatic Rings: 1

Heavy Atoms: 23

QED Weighted: 0.40

Np Likeness Score: -0.86

References

1. McElhinney RS, McCormick JE, Bibby MC, Double JA, Radacic M, Dumont P..  (1996)  Nucleoside analogs. 14. The synthesis of antitumor activity in mice of molecular combinations of 5-fluorouracil and N-(2-Chloroethyl)-N-nitrosourea moieties separated by a three-carbon chain.,  39  (7): [PMID:8691470] [10.1021/jm9507237]

Source

Source(1):

• Scientific Literature